Follow the 올릭스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 올릭스 has logged 5 reports. Market capitalisation: €2,460.4bn. The latest transaction was reported on 7 July 2026 (Purchase). Among the most active insiders: 미래에셋자산운용. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
OLIX es una empresa de biotecnología centrada en el desarrollo de terapias basadas en ARN. Cotiza en el mercado XKRX.